Volunteer for Research

Clinical Trial Seeks to Get AHEAD of Alzheimer’s Disease

Mayo Clinic has joined over 70 other institutions around the US and Canada to test an exciting new drug in the fight against Alzheimer’s disease. This groundbreaking clinical trial, called the AHEAD Study, seeks to delay or prevent the onset of Alzheimer’s disease by targeting the earliest known changes - well before the first signs of memory loss occur.

To read more about this clinical trial, click here.

To speak with someone about the AHEAD Study, email our study coordinator, Mr. Anton Thomas, at Thomas.anton@mayo.eduor call 904-953-4096. You can also call the Mayo Clinic Alzheimer’s Disease Research Center at 904-953-6523

Everything we know today about Alzheimer’s disease and AD-related dementia is because someone volunteered to participate in a research study. As the search for a cure continues, it is critically important for everyone to be represented. View Keretha's story below.

The Mayo Clinic Alzheimer’s Disease Research Center (ADRC) offers a variety of studies into healthy aging, early signs of memory loss, improved diagnostic tools, and the biological and genetic factors that protect against or convey risk for Alzheimer’s disease and AD-related dementia. Our ADRC also offers clinical trials for participants who want to advance the search for new and effective dementia therapies.